Sotera Health Company (SHC)

Market Cap	4.59B +16.9%
Revenue (ttm)	1.16B +5.7%
Net Income	77.95M +75.6%
EPS	0.27 +72.2%
Shares Out	284.09M
PE Ratio	59.85
Forward PE	16.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,718,919
Open	16.78
Previous Close	16.72
Day's Range	15.96 - 16.98
52-Week Range	9.53 - 19.85
Beta	1.83
Analysts	Buy
Price Target	20.67 (+27.91%)
Earnings Date	Feb 24, 2026

About SHC

Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets. The Nordion segment pr...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 20, 2020
• Employees: 3,000
• Stock Exchange: NASDAQ
• Ticker Symbol: SHC
• Website: https://soterahealth.com

Financial Performance

In 2025, Sotera Health Company's revenue was $1.16 billion, an increase of 5.74% compared to the previous year's $1.10 billion. Earnings were $77.95 million, an increase of 75.80%.

Analyst Summary

According to 7 analysts, the average rating for SHC stock is "Buy." The 12-month stock price target is $20.67, which is an increase of 27.91% from the latest price.

Price Target

$20.67

(27.91% upside)

Analyst Consensus: Buy